ANTARES PHARMA INC's ticker is and the CUSIP is 036642906. A total of 1 filers reported holding ANTARES PHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $349,000 | +160.4% | 85,000 | +127.3% | 0.00% | – |
| Q4 2021 | $134,000 | -55.0% | 37,400 | -54.3% | 0.00% | – |
| Q3 2021 | $298,000 | -59.8% | 81,900 | -51.9% | 0.00% | -100.0% |
| Q2 2021 | $742,000 | +11.2% | 170,100 | +4.8% | 0.00% | 0.0% |
| Q1 2021 | $667,000 | +383.3% | 162,300 | +370.4% | 0.00% | – |
| Q4 2020 | $138,000 | +150.9% | 34,500 | +69.1% | 0.00% | – |
| Q3 2020 | $55,000 | -43.9% | 20,400 | -42.7% | 0.00% | – |
| Q2 2020 | $98,000 | -47.6% | 35,600 | -55.2% | 0.00% | -100.0% |
| Q1 2020 | $187,000 | -72.4% | 79,400 | -45.0% | 0.00% | -60.0% |
| Q4 2019 | $678,000 | +417.6% | 144,300 | +267.2% | 0.01% | +400.0% |
| Q3 2019 | $131,000 | -40.7% | 39,300 | -41.6% | 0.00% | -50.0% |
| Q2 2019 | $221,000 | +63.7% | 67,300 | +51.6% | 0.00% | 0.0% |
| Q1 2019 | $135,000 | -22.9% | 44,400 | -31.2% | 0.00% | 0.0% |
| Q4 2018 | $175,000 | +12.2% | 64,500 | +38.7% | 0.00% | +100.0% |
| Q3 2018 | $156,000 | +57.6% | 46,500 | +21.1% | 0.00% | 0.0% |
| Q2 2018 | $99,000 | +41.4% | 38,400 | +21.1% | 0.00% | 0.0% |
| Q1 2018 | $70,000 | +400.0% | 31,700 | +359.4% | 0.00% | – |
| Q4 2017 | $14,000 | +250.0% | 6,900 | +475.0% | 0.00% | – |
| Q3 2017 | $4,000 | -98.1% | 1,200 | -98.1% | 0.00% | -100.0% |
| Q2 2017 | $208,000 | -7.6% | 64,500 | -18.5% | 0.00% | -33.3% |
| Q1 2017 | $225,000 | +99.1% | 79,100 | +62.4% | 0.00% | +200.0% |
| Q4 2016 | $113,000 | -71.0% | 48,700 | -47.9% | 0.00% | -90.0% |
| Q2 2013 | $389,000 | – | 93,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 22 | $0 | 0.00% |